Sotatercept shows promise for a type of pulmonary hypertension linked to heart failure with preserved EF

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary ...
Pharmabiz

EU approves Bayer’s Kerendia for new indication in adult patients with heart failure with LVEF =40%

EU approves Bayer’s Kerendia for new indication in adult patients with heart failure with LVEF =40%: Berlin Tuesday, March 31, 2026, 14:00 Hrs [IST] Bayer, a global enterprise w ...

Hengrui Pharma and Braveheart Bio Announce Positive Phase 2 Results with HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy

HRS-1893 (also known as BHB-1893) is a selective, small-molecule, cardiac myosin inhibitor engineered to improve heart performance in patients with HCM. By modulating cardiac contractility, HRS-1893 ...

Treatment guided by noninvasive device to monitor lung congestion improves heart failure outcomes

Treatment management guided by the use of a noninvasive device to monitor fluid accumulation in the lungs substantially reduced hospitalizations and deaths among patients with heart failure with ...
Healio

Patient-first alerts of worsening HF may ‘translate early detection into timely care’

Smartphone notifications that alerted patients first, rather than their physicians, of early heart failure decompensation were feasible and safe, according to results from the NOTIFY-HF pilot ...
The New England Journal of Medicine

Discontinuation of Beta-Blocker Therapy after Myocardial Infarction

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...
News Medical

New drug sotatercept shows benefit in CpcPH-HFpEF patients

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced significant improvements in blood pressure and ...
TCTMD

SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF

The trial enrolled just half of its planned patients, leaving spironolactone’s role in HFpEF and HFmrEF still up in the air.
EurekAlert!

Study finds no significant benefit of spironolactone in HFpEF or HFmrEF

A trial testing the aldosterone blocker spironolactone in patients with heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF) did not ...
EurekAlert!

Sotatercept shows promise for an uncommon type of pulmonary hypertension linked to heart failure with preserved ejection fraction

Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced significant improvements in blood pressure and ...
Onlymyhealth on MSN

Ejection fraction explained: Know its normal range and what it means for the heart

Is your heart functioning properly? There is a test which can measure this, which is often recommended by medical professionals. Ejection fraction (EF) is a measurement, expressed as a percentage, of ...

BioVentrix, Inc. Announces German Reimbursement Designation

German Hospitals Now Eligible to Negotiate Full Coverage for Revivent Therapy Our team has successfully secured full ...